News

24/07/14
Half-year revenues and results

Increase in revenues in line with full-year targets (+1.2%)

Very strong...

[more]
21/07/14
Stallergenes expands Latin American presence with acquisition of ALERGO PHARMA S.R.L. in Argentina

Antony (France), 21 July 2014 – STALLERGENES, a global healthcare company...

[more]

Follow us on :

STALLERGENES, A GLOBAL ALLERGY PLAYER


Stallergenes is a global pharmaceutical company with leading innovation, provider of allergy solutions all around the world. 

Stallergenes has a comprehensive approach of the allergic diseases with a complete portfolio combining diagnosis products and treatments and has brought the new generation of allergen immunotherapy treatments.